Lydus Medical

Automated Microvascular Anastomosis for Ultrasmall Vessels

Health Tech & Life Sciences
Active
Series A Ra'anana Founded 2017
Total raised
$2.7M
Last: Series A 2022-09
Stage
Series A
Founded
2017
Headcount
8
HQ
Ra'anana
Sector
Health Tech & Life Sciences

About

Lydus Medical is developing a novel system for automating the creation of small blood vessel anastomoses. The company's Vesseal is an automated microvascular suturing device that delivers a standardized, thread-only, omni-vessel anastomosis to enable simple, fast, safe, and effective procedures.

Vesseal has received FDA clearance.

Funding history · 2 rounds · $2.7M total

2022-09
Series A Undisclosed
2021-05
Seed $2.7M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

surgeonssurgery-toolscardiologysurgerymedical-devicesvascular